NCT02880410

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Newly Diagnosed Glioblastoma

• Status: Terminated
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: Monteris Medical · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in combination with standard of care radiation therapy and temozolomide for the treatment of newly diagnosed glioblastomas (GBM).

Conditions

• Glioblastoma

Interventions

Type	Name	Description
DEVICE	NeuroBlate System	Laser Interstitial Thermal Therapy
DRUG	Radiation therapy and temozolomide	Radiation therapy and temozolomide

Timeline

• Start date: 2017-08-15
• Primary completion: 2018-09-14
• Completion: 2018-09-14
• First posted: 2016-08-26
• Last updated: 2024-04-12

Locations

4 sites across 1 country: United States

Regulatory

• FDA-regulated device study